Peripheral Neuropathies: Current Evidence for Alternative Treatment Regimens and Treatment Combinations

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 2014 Dec 30

PMID 25546753

Authors

C Sommer

Affiliations

Soon will be listed here.

References

Hughes R, van Doorn P . Corticosteroids for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2012; (8):CD001446. DOI: 10.1002/14651858.CD001446.pub4. View

Hughes R, Mehndiratta M . Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2012; (8):CD002062. DOI: 10.1002/14651858.CD002062.pub2. View

Mehndiratta M, Hughes R . Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2012; (9):CD003906. DOI: 10.1002/14651858.CD003906.pub3. View

Eftimov F, Winer J, Vermeulen M, de Haan R, van Schaik I . Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2014; (12):CD001797. DOI: 10.1002/14651858.CD001797.pub3. View

Hughes R, Bensa S, Willison H, Van den Bergh P, Comi G, Illa I . Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol. 2001; 50(2):195-201. DOI: 10.1002/ana.1088. View

van Koningsveld R, Schmitz P, Meche F, Visser L, Meulstee J, van Doorn P . Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial. Lancet. 2004; 363(9404):192-6. DOI: 10.1016/s0140-6736(03)15324-x. View

. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Lancet. 1997; 349(9047):225-30. View

Tackenberg B, Lunemann J, Steinbrecher A, Rothenfusser-Korber E, Sailer M, Bruck W . Classifications and treatment responses in chronic immune-mediated demyelinating polyneuropathy. Neurology. 2007; 68(19):1622-9. DOI: 10.1212/01.wnl.0000260972.07422.ea. View

Piepers S, Van den Berg-Vos R, van der Pol W, Franssen H, Wokke J, Van Den Berg L . Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial. Brain. 2007; 130(Pt 8):2004-10. DOI: 10.1093/brain/awm144. View

10.

Garssen M, van Koningsveld R, van Doorn P, Merkies I, Scheltens-de Boer M, van Leusden J . Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study. J Neurol Neurosurg Psychiatry. 2007; 78(9):1012-3. PMC: 2117875. DOI: 10.1136/jnnp.2006.102731. View

11.

Muley S, Kelkar P, Parry G . Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids. Arch Neurol. 2008; 65(11):1460-4. DOI: 10.1001/archneur.65.11.1460. View

12.

Eftimov F, Winer J, Vermeulen M, de Haan R, van Schaik I . Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2009; (1):CD001797. DOI: 10.1002/14651858.CD001797.pub2. View

13.

. Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study. Lancet Neurol. 2009; 8(2):158-64. DOI: 10.1016/S1474-4422(08)70299-0. View

14.

. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the.... J Peripher Nerv Syst. 2010; 15(1):1-9. DOI: 10.1111/j.1529-8027.2010.00245.x. View

15.

Cocito D, Paolasso I, Antonini G, Benedetti L, Briani C, Comi C . A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol. 2009; 17(2):289-94. DOI: 10.1111/j.1468-1331.2009.02802.x. View

16.

Chaudhry V, Cornblath D . An open-label trial of rituximab (Rituxan®) in multifocal motor neuropathy. J Peripher Nerv Syst. 2010; 15(3):196-201. DOI: 10.1111/j.1529-8027.2010.00270.x. View

17.

Cocito D, Grimaldi S, Paolasso I, Falcone Y, Antonini G, Benedetti L . Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis. Eur J Neurol. 2011; 18(12):1417-21. DOI: 10.1111/j.1468-1331.2011.03495.x. View

18.

Umapathi T, Hughes R, Nobile-Orazio E, Leger J . Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy. Cochrane Database Syst Rev. 2012; (4):CD003217. DOI: 10.1002/14651858.CD003217.pub4. View

19.

Nobile-Orazio E, Cocito D, Jann S, Uncini A, Beghi E, Messina P . Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. Lancet Neurol. 2012; 11(6):493-502. DOI: 10.1016/S1474-4422(12)70093-5. View